FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/088182 [Registered on: 03/06/2025] Trial Registered Prospectively
Last Modified On: 23/06/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Other 
Public Title of Study   Role of Homoeopathic Medicine in Obesity in children 
Scientific Title of Study   Comparative Efficacy of Individualized Homoeopathic Medicines and Fucus vesiculosus 3X in Overweight and Obese Children: Randomized, Single Blind trial 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Renu Mittal 
Designation  Research Officer Homoeopathy 
Affiliation  Central Council for Research in Homoeopathy 
Address  Room No 304, Department: Scheduled Caste Sub Pan. D Block Janakpuri, New Delhi South West DELHI 110058 India

South West
DELHI
110058
India 
Phone  9717511115  
Fax    
Email  renumittal8@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Renu Mittal 
Designation  Research Officer Homoeopathy 
Affiliation  Central Council for Research in Homoeopathy 
Address  Room No 304, Department: Scheduled Caste Sub Pan. D Block Janakpuri, New Delhi South West DELHI 110058 India

South West
DELHI
110058
India 
Phone  9717511115  
Fax    
Email  renumittal8@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Divya Taneja 
Designation  Research Officer Homoeopathy 
Affiliation  Central Council for Research in Homoeopathy 
Address  Room No 309, Department: Public Health. D Block Janakpuri, New Delhi South West DELHI 110058 India

South West
DELHI
110058
India 
Phone  9810305068  
Fax    
Email  drdivyataneja@gmail.com  
 
Source of Monetary or Material Support  
Central Council for Research in Homoeopathy, 61-65 institutional area, opposite d block, Janakpuri, New Delhi, India, Pin code- 110058  
 
Primary Sponsor  
Name  Central Council for Research in Homoeopathy  
Address  Central Council for Research in Homoeopathy, Jawahar Lal Nehru Chikitsa Avum Anusandhan Bhawan, 61-65, Institutional Area, Opposite D Block Janakpuri  
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 6  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Uttam Singh  Central Research Institute of Homoeopathy  Room No: 3,Department- Homoeopathy, Division- Clinical Research, Address: Sector 26, Pratap Nagar, Jaipur, Rajasthan 302033
Jaipur
RAJASTHAN 
9679593673

druttam01@gmail.com 
Dr G R C Reddy  Clinical Research Unit(Homoeopathy)  Room No 304 Department: SCSP, Division: Clinical research, Address: Old maternity Hospital Campus, tirupati-517507, Chittoor District, Andhra Pradesh
Chittoor
ANDHRA PRADESH 
9441208007

dr.grcreddy@gmail.com 
Dr Pankhuri Mishra  Dr DP Rastogi Central Research Institute  Room No 205 Department: Technical(Homoeopathy), Division: Clinical research, Address: A-1/1 Opp HCL, Sector 24, Noida, Uttar Pradesh 201301
Gautam Buddha Nagar
UTTAR PRADESH 
9968533904

drpankhccrh@gmail.com 
Dr Ashish Shivadikar  Regional Research Institute (H)  Room no. -009,Department- Homoeopathy, Division-Clinical research, Address: Plot no. 38,39, Khargar,Navi Mumbai, Maharashtara- 410210
Mumbai
MAHARASHTRA 
7021436030

ashishshivadikar@gmail.com 
Dr Deepthi Gilla  Regional Research Institute(H)  Room no.9 Department: Out-patient Department Division: Clinical Research , Address: Street Number 4, Vikrampuri, Habsiguda, Hyderabad, Telangana 500007
Hyderabad
TELANGANA 
8111990221

drdeepthigilla@gmail.com 
Dr Tanya Aggarwal  Regional Research Institute(H)  Room No 101, Department: SCSP, Division: Clinical Research, Address: Chhota Pathuram, Siliguri, West Bengal 734011
Darjiling
WEST BENGAL 
9873744058

dr.tanyaaggarwal@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 7  
Name of Committee  Approval Status 
Central Ethics Committee  Approved 
Institutional Ethical Committee  Approved 
Institutional Ethical Committee  Approved 
Institutional Ethical Committee  Approved 
Institutional Ethical Committee  Approved 
Institutional Ethical Committee  Approved 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E66||Overweight and obesity,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Fucus Vesiculosus  Fucus Vesiculosus will be prescribed via oral route of administration for duration of 12 months 
Intervention  Individualized Homoeopathic Medicine  Individualized homoeopathic medicines obtained after case taking will be prescribed via oral route of administration for duration of 12 months 
 
Inclusion Criteria  
Age From  7.00 Year(s)
Age To  18.00 Year(s)
Gender  Both 
Details  Participants with age 7 to 18 years, both sexes. Children of 7 to 18 years of age with BMI greater than one SD and lesser than three SD; participants with fasting serum glucose lesser than 126mg/dl 
 
ExclusionCriteria 
Details  Participants already undergoing treatment(homoeopathic, nutritional) for obesity within last 3 months. Participants currently using metformin, orlistat, insulin, other anti-diabetic medication;contraceptive pills;thiazide;antipsychotics using these medicines regularly over the last 15 days. Suffering from any condition that can prevent physical exercises like walking, aerobic exercises; suffering from uncontrolled hypertension; suffering from pre-diagnosed or self reported Down syndrome and intellectual disabilities; refusing to comply with the instructions of LSM, refusing assent for the homoeopathic treatment 
 
Method of Generating Random Sequence   Stratified randomization 
Method of Concealment    
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Body Mass Index for all age groups  Assessed monthly till end of 12 month 
 
Secondary Outcome  
Outcome  TimePoints 
Changes in weight, height, waist circumference,waist-hip ratio, lean muscle mass,body fat percentage, lipid profile, liver function test, thyroid profile,fasting glucose,fasting insulin and HbA1c, physical activity Questionnaire, HRQOL   Assessed monthly till end of 12 months 
 
Target Sample Size   Total Sample Size="296"
Sample Size from India="296" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a single blind randomized study and will be undertaken at 5 units of central council for research in Homoeopathy with an objective to evaluate the efficacy of individualized homoeopathic medicines and fucus vesiculosus 3x in overweight and obese children. The objective of the study is to assess the changes in Body Mass index among overweight and obese children and other physical parameters 
Close